KIMBERLY WINTERS: Open Payments
NPI 1609558592 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$987 in 50 payments from 22 companies in 2025. Trend: 2023 $48 · 2024 $291 · 2025 $987
Food & beverage: $987
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $191 |
| Vantive US Healthcare LLC | 6 | $185 |
| Janssen Biotech, Inc. | 4 | $68 |
| Mallinckrodt Hospital Products Inc. | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Phathom Pharmaceuticals, Inc. | 4 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| HARMONY BIOSCIENCES LLC | 2 | $41 |
| Lilly USA, LLC | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
Products named: Renal - PD, RINVOQ, TREMFYA, ACTHAR, VOQUEZNA, CAPLYTA, WAKIX, GATTEX.
Industry payments across ND — which companies pay providers there.
